Cho named Abbott Korea pharmaceutical primary care chief

Published: 2008-10-22 06:52:00

Updated: 2008-10-22 06:52:00

Abbott Korea has announced that Cho Ki-whan, executive managing director, was named as primary care leader of pharmaceutical business unit, effective October 20.

Cho will be responsible for PCD business unit involving prescription drugs.

Cho joined Abbott Korea in 2004 as the head of medica...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK